Legend Biotech Corp. (LEGN)
18.57
-0.75
(-3.88%)
USD |
NASDAQ |
Oct 02, 16:00
18.57
0.00 (0.00%)
After-Hours: 20:00
Legend Biotech Price to Book Value : 2.926 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.926 |
| October 01, 2026 | 3.044 |
| September 30, 2026 | 3.134 |
| September 29, 2026 | 2.966 |
| September 28, 2026 | 2.934 |
| September 25, 2026 | 3.011 |
| September 24, 2026 | 3.004 |
| September 23, 2026 | 2.907 |
| September 22, 2026 | 2.937 |
| September 21, 2026 | 2.92 |
| September 18, 2026 | 2.775 |
| September 17, 2026 | 2.770 |
| September 16, 2026 | 2.679 |
| September 15, 2026 | 2.784 |
| September 14, 2026 | 2.92 |
| September 11, 2026 | 2.937 |
| September 10, 2026 | 3.024 |
| September 09, 2026 | 3.138 |
| September 08, 2026 | 3.229 |
| September 04, 2026 | 3.391 |
| September 03, 2026 | 3.427 |
| September 02, 2026 | 3.450 |
| September 01, 2026 | 3.330 |
| August 31, 2026 | 3.275 |
| August 28, 2026 | 3.133 |
| Date | Value |
|---|---|
| August 27, 2026 | 3.230 |
| August 26, 2026 | 3.259 |
| August 25, 2026 | 3.356 |
| August 24, 2026 | 3.300 |
| August 21, 2026 | 3.438 |
| August 20, 2026 | 3.350 |
| August 19, 2026 | 3.561 |
| August 18, 2026 | 3.454 |
| August 17, 2026 | 3.254 |
| August 14, 2026 | 3.21 |
| August 13, 2026 | 3.194 |
| August 12, 2026 | 3.254 |
| August 11, 2026 | 3.44 |
| August 10, 2026 | 3.256 |
| August 07, 2026 | 3.270 |
| August 06, 2026 | 3.038 |
| August 05, 2026 | 3.002 |
| August 04, 2026 | 3.015 |
| August 03, 2026 | 2.996 |
| July 31, 2026 | 2.923 |
| July 30, 2026 | 3.002 |
| July 29, 2026 | 2.970 |
| July 28, 2026 | 3.000 |
| July 27, 2026 | 3.037 |
| July 24, 2026 | 3.502 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 15.18 |
| Ionis Pharmaceuticals, Inc. | 16.40 |
| Johnson & Johnson | 7.256 |
| Arbutus Biopharma Corp. | 3.399 |
| Capricor Therapeutics, Inc. | 2.112 |
Price to Book Value Related Metrics
| PS Ratio | 2.726 |
| Price | 18.57 |
| Earnings Yield | -2.72% |
| Market Cap | 3.598B |